Tag: Biotech

Biotech Startup Tahoe Therapeutics Raised $30 Million To Build AI Models Of Living Cells

Tahoe Therapeutics, a biotech startup co-founded by Kevin Shokat, Nima Alidoust, Johnny Yu, and Hani Goodarzi, is making

How A 60-Year-Old Drug Developer Built $4.4 Billion Krystal Biotech To Treat ‘Butterfly Skin Disease’

Suma Krishnan: The Visionary Behind Krystal Biotech's Success By Amy Feldman, Forbes Staff Longtime drug developer Suma Krishnan

Make Your Students Feel Like Real Scientists With Biotech for Life

Science and mystery collide in Ward's Biotech for Life Science Kit, Capturing a Bigfoot Is No Small Feat.

Founder Of Biotech Firm Caris Life Sciences Becomes A Billionaire After IPO

Caris Life Sciences founder David Dean HalbertCaris Life Sciences The successful IPO of Caris Life Sciences makes its

Biotech firm aims to create ‘ChatGPT of biology’ – will it work?

Basecamp researchers gathering genetic data in MaltaGreg Funnell A revolutionary biotech company named Basecamp Research has been diligently

Face Tattoos For Stress? The Real-Time Biotech Wearable Trackers

Facial Recognition AI: The Rise of Stress-Tracking Skin Wearables In a world where technology continues to push boundaries,

Biotech Stock for Options Bears to Target Right Now

Biotech stock Crispr Therapeutics Inc's (NASDAQ:CRSP) recent rally seems to be losing steam as the shares are on

China’s quickly gaining an edge over the U.S. in biotech

China's Rapid Rise in Biotechnology: A Global Game-Changer In the realm of global technological competition, the focus has

Activists upend mRNA biotech advance with political power

Isabella Cueto, a renowned writer covering the leading causes of death and disability, particularly chronic diseases, shines a

Merck held talks to buy Swiss biotech MoonLake for more than $3bn

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this

This Biotech Startup Raised $34 Million For Urine-Based Tests To Help Diagnose Cancer

Phase Scientific International, a Hong Kong-based biotech startup, has recently secured $34 million in a Series A funding

FDA’s Conditional Approval Plan Would Unleash Biotech Innovation

The FDA is on the brink of a groundbreaking change that could revolutionize the approval process for rare